CAPR
CAPR
US14070B3096
Capricor Therapeutics, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
455.23M EUR
1.4B EUR
1.75B EUR
1.66B EUR
Enterprise Value
318.8M EUR
1.47B EUR
1.66B EUR
1.38B EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-5.4x
--
--
--
Price to Sales
--
--
--
--
Price to Book
1.85x
5.68x
6.29x
5.41x
EV/Revenue
--
--
--
--
EV/EBITDA
-2.4x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-19.59%
-9.27%
-6.5%
-4.47%
ende